The online version of this article (doi:10.1186/1476-7120-5-32) contains supplementary material, which is available to authorized users.
The author(s) declare that they have no competing interests.
AL and KG carried out study design, echocardiography imaging and measurements, data analyses and reporting. MR designed and supervised all exercise programs, and critically revised the manuscript. AN designed and performed all blood analyses and revised the manuscipt. HH designed and performed statistical analyses together with AL, and critically revised the manuscript. IV caried out study design and exercise program planning, and revised the manuscript critically. All authors read and approved the final manuscript.
Myocardial diastolic tissue velocities are reduced already in newly onset Type 2 diabetes mellitus (T2D). Poor disease control may lead to left ventricular (LV) systolic dysfunction and heart failure. The aim of this study was to assess the effects of exercise training on myocardial diastolic function in T2D patients without ischemic heart disease.
48 men (52.3 ± 5.6 yrs) with T2D were randomized to supervised training four times a week and standard therapy (E), or standard treatment alone (C) for 12 months. Glycated hemoglobin (HbA1c), oxygen consumption (VO2max), and muscle strength (Sit-up) were measured. Tissue Doppler Imaging (TDI) was used to determine the average maximal mitral annular early (Ea) and late (Aa) diastolic as well as systolic (Sa) velocities, systolic strain (ε) and strain rate (έ) from the septum, and an estimation of left ventricular end diastolic pressure (E/Ea).
Exercise capacity (VO2max, E 32.0 to 34.7 vs. C 32.6 to 31.5 ml/kg/min, p = .001), muscle strength (E 12.7 to 18.3 times vs. C 14.6 to 14.7 times, p < .001), and HbA1c (E 8.2 to 7.5% vs. C 8.0 to 8.4%, p = .006) improved significantly in the exercise group compared to the controls (ANOVA). Systolic blood pressure decreased in the E group (E 144 to 138 mmHg vs. C 146 to 144 mmHg, p = .04). Contrary to risk factor changes diastolic long axis relaxation did not improve significantly, early diastolic velocity Ea from 8.1 to 7.9 cm/s for the E group vs. C 7.4 to 7.8 cm/s (p = .85, ANOVA). Likewise, after 12 months the mitral annular systolic velocity, systolic strain and strain rate, as well as E/Ea were unchanged.
Exercise training improves endurance and muscle fitness in T2D, resulting in better glycemic control and reduced blood pressure. However, myocardial diastolic tissue velocities did not change significantly. Our data suggest that a much longer exercise intervention may be needed in order to reverse diastolic impairment in diabetics, if at all possible.
Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T: Association of diabetes mellitus with coronary aterosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol 1993, 137: 1328-1340. PubMed
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329: 977-986. 10.1056/NEJM199309303291401 CrossRef
Loimaala A, Groundstroem K, Majahalme S, Nenonen A, Vuori I: Impaired myocardial function in newly onset Type 2 diabetes associates with arterial stiffness. Eur J Echocardiography 2006, 7(5):341-347. 10.1016/j.euje.2005.07.001 CrossRef
Hillis GS, Möller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK: Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004, 43: 360-367. 10.1016/j.jacc.2003.07.044 CrossRefPubMed
UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998, 352: 837-852. 10.1016/S0140-6736(05)61359-1 CrossRef
Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, Marian AJ: Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001, 104: 317-324. 10.1161/hc2801.094031 CrossRefPubMedPubMedCentral
World Medical Organization: Declaration of Helsinki. Br Med J 1996, 313: 1448-1449.
Kirstein P, Carlson K: Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma. Clin Chem Acta 1981, 113(2):123-34. 10.1016/0009-8981(81)90146-7 CrossRef
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502. PubMed
Nagueh SF, Bachincski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ: Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001, 104(2):128-130. CrossRefPubMedPubMedCentral
Sylvén C, Sarkar N, Rück A, Drvota V, Y-Hassa S, Lind B, Nygren A, Källner G, Blomberg P, van der Linden J, Lindblom D, Brodin LÅ, Islam KB: Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A 165 plasmid in patients with inoperable angina pectoris. Coron Artery Dis 2001, 12: 239-243. 10.1097/00019501-200105000-00010 CrossRefPubMed
Weidemann F, Breinig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM: Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. A prospective strain rate imaging study. Circulation 2003, 108: 1299-1301. 10.1161/01.CIR.0000091253.71282.04 CrossRefPubMed
Amos AF, McCarty DJ, Zimmeth P: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997, 14(Suppl 5):S1-S85.10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I PubMed
Tuomilehto J, Lindström J, Erikson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344: 1343-1350. 10.1056/NEJM200105033441801 CrossRefPubMed
Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabet Rev 1997, 5: 294-315.
Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J, for the Treatment of Hypertension Study Research Group: Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995, 91: 698-706. CrossRefPubMed
- Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II